Published in Gastroenterology on April 01, 1979
Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol (2004) 2.81
Plasma amino-acid patterns in liver disease. Gut (1982) 1.19
Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect. J Clin Invest (1985) 1.05
Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions. Gut (2002) 0.90
Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma. Gut (2002) 0.88
Endocrine aspects of liver disease. Br Med J (1980) 0.86
Correction of altered plasma amino acid pattern in cirrhosis of the liver by somatostatin. Gut (1984) 0.83
Metabolic handling of orally administered glucose in cirrhosis. J Clin Invest (1993) 0.78
Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol (1966) 8.26
The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med (1973) 6.65
Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet (1972) 5.17
Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut (1980) 4.09
Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med (1971) 3.23
Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet (1968) 3.10
The epidemiology of testicular cancer in young adults. Am J Epidemiol (1980) 2.90
The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med (1979) 2.84
Spread of acute type-B hepatitis in London. Lancet (1973) 2.82
Measurement of liver-iron concentration in needle-biopsy specimens. Lancet (1971) 2.65
Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. N Engl J Med (1966) 2.65
Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury. Lancet (1971) 2.61
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet (1970) 2.60
Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology (1975) 2.58
Partial nodular transformation of the liver with portal hypertension. Am J Med (1966) 2.45
Cell-mediated immunity in patients positive for hepatitis-associated antigen. Br Med J (1972) 2.39
Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. J Pediatr (1993) 2.32
Characterization of seven C-peptide antisera. Diabetes (1978) 2.29
A randomized trial of percutaneous transhepatic cholangiography with the Chiba needle versus endoscopic retrograde cholangiography for bile duct visualization in jaundice. Gastroenterology (1976) 2.25
Diagnosis of Gilbert's syndrome: role of reduced caloric intake test. Br Med J (1973) 2.21
Impaired delayed hypersensitivity in primary biliary cirrhosis. Lancet (1969) 2.19
Is primary biliary cirrhosis an immune complex disease? Lancet (1977) 2.15
The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology (1982) 2.11
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
Complications of diuretic therapy in hepatic cirrhosis. Lancet (1966) 2.09
Hereditary spherocytosis with secondary haemochromatosis. Lancet (1968) 2.00
Immune complexes in acute and chronic liver disease. Clin Exp Immunol (1978) 1.93
The pathology of hepatitis C. Hepatology (1992) 1.92
The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitus. Diabetologia (1978) 1.92
Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease. Lancet (1975) 1.90
Sex-related differences among 100 patients with alcoholic liver disease. Br Med J (1977) 1.89
Induction of remission in hepatocellular carcinoma with doxorubicin. Lancet (1978) 1.86
Hepatitis-associated antigen in chronic liver disease. Lancet (1969) 1.82
Association of primary sclerosing cholangitis with HLA-B8. Gut (1983) 1.79
Hemolytic anemia in Wilson's disease. N Engl J Med (1967) 1.78
Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy. Lancet (1968) 1.67
Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis. Gut (1967) 1.67
Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. Gut (1981) 1.67
The Budd-Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. Gastroenterology (1975) 1.66
Presentation and course of asymptomatic primary biliary cirrhosis. Gastroenterology (1977) 1.65
C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus. Diabetes (1977) 1.65
Immunological studies in an epidemic of infective, short-incubation hepatitis. Lancet (1972) 1.62
Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen. Lancet (1972) 1.60
Renal and intrarenal blood-flow in cirrhosis of the liver. Lancet (1971) 1.60
Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet (1972) 1.59
Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut (1986) 1.58
Arsenic and noncirrhotic portal hypertension. Gastroenterology (1974) 1.57
Vitamin A treatment for night blindness in primary biliary cirrhosis. Br Med J (Clin Res Ed) (1984) 1.57
Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients. J Hepatol (1986) 1.55
Percutaneous liver biopsy in patients with large bile duct obstruction. Gastroenterology (1975) 1.53
Chronic pancreatitis: a cause of cholestasis. Gut (1977) 1.51
Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis. Clin Exp Immunol (1972) 1.50
Halothane hepatitis. Lancet (1978) 1.50
Is mitochondrial antibody diagnostic of primary biliary cirrhosis? Gut (1981) 1.50
Studies in alcoholic liver disease in Britain. I. Clinical and pathological patterns related to natural history. Gut (1974) 1.50
Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). A study of 42 families. N Engl J Med (1967) 1.48
Hepatic reactions associated with ketoconazole in the United Kingdom. Br Med J (Clin Res Ed) (1987) 1.47
Treatment of ascites by continuous ultrafiltration and reinfusion of protein concentrate. Lancet (1974) 1.46
D-penicillamine treatment improves survival in primary biliary cirrhosis. Lancet (1981) 1.45
Diagnosis of primary cancer of the liver. Br Med J (1971) 1.45
Clinical diagnosis of the Budd-Chiari syndrome. A report of six cases. Am J Med (1967) 1.45
Immunoglobulin-containing cells in the liver. Clin Exp Immunol (1969) 1.44
Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol (1983) 1.43
Peripheral blood lymphocyte populations in chronic liver disease. Clin Exp Immunol (1976) 1.43
Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest (1978) 1.42
Fatal aplastic anaemia after mesalazine. Lancet (1994) 1.42
Histological demonstration of copper and copper-associated protein in chronic liver diseases. J Clin Pathol (1978) 1.42
Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes. Diabetes (1978) 1.41
Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand (1981) 1.40
Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers. Gut (1983) 1.40
Hypertrophic hepatic osteoarthropathy. Clinical, roentgenologic, biochemical, hormonal and cardiorespiratory studies, and review of the literature. Am J Med (1979) 1.39
Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study. Gastroenterology (1981) 1.38
Diagnosis of halothane-related hepatitis. Proc R Soc Med (1975) 1.38
Acute fatty liver of pregnancy and the microvesicular fat diseases. Gut (1983) 1.37
Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host disease. Lancet (1980) 1.36
Prognosis of chronic persistent hepatitis. Lancet (1970) 1.35
Double-stranded DNA-binding capacity of serum in acute and chronic liver disease. Clin Exp Immunol (1976) 1.35
Presymptomatic Wilson's disease. Lancet (1967) 1.33
The serum concentration of the third component of complement beta-1C-beta-1A in liver disease. Gut (1971) 1.33
Accuracy of computed tomography in diagnosis of fatty liver. Br Med J (1980) 1.32
Extracorporeal pig-liver perfusoon in treatment of hepatic coma due to fulminant hepatitis. Lancet (1971) 1.31
Halothane hepatitis. Gut (1971) 1.31
Primary biliary cirrhosis or sarcoidosis--or both. N Engl J Med (1972) 1.30
Chronic hepatitis. Gut (1974) 1.30
Hepatic coma due to acute hepatic necrosis treated by exchange blood-transfusion. Lancet (1967) 1.30
Role of hepatitis-B antigen carriers in non-parenteral transmission of the hepatitis-B virus. Lancet (1974) 1.29
Immunological and histological studies in primary biliary cirrhosis. J Clin Pathol (1970) 1.29
Emergency oesophageal transection in uncontrolled variceal haemorrhage. Br J Surg (1973) 1.29
Chronic liver disease and mitochondrial antibodies: a family study. Br Med J (1972) 1.29
Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis. Acta Endocrinol (Copenh) (1979) 1.28
The value of percutaneous cholangiography. Br J Surg (1965) 1.28
HLA-B8, immunoglobulins, and antibody responses in alcohol-related liver disease. J Clin Pathol (1980) 1.28
Serum-25-hydroxy-vitamin-D in untreated parenchymal and cholestatic liver disease. Lancet (1976) 1.27
Role of percutaneous transhepatic obliteration of varices in the management of hemorrhage from gastroesophageal varices. Gastroenterology (1981) 1.26
Wilson's disease, presenting as chronic active hepatitis. Gastroenterology (1978) 1.26
Variation in 125I-insulin absorption and blood glucose concentration. Diabetologia (1979) 1.26